Tokishakuyakusan, a Kampo medicine, attenuates endometriosis‐like lesions and hyperalgesia in murine with endometriosis‐like symptoms
article
OA: closed
CC0
⤵ 7 in-corpus citations
Abstract
Abstract Problem How are the effects of Tokishakuyakusan (TSS), a traditional Japanese medicine (Kampo) on murine endometriosis model? Methods BALB/c mice were used for making the murine endometriosis model. Homogeneous uterus was surgically implanted with lipopolysaccharide (LPS) in peritoneal cavity. We administered 2 weeks of TSS (1.0 g/kg) orally. Upon treatment completion, we performed the hot plate test for all mice and collected blood samples before sacrifice. Then, the endometriosis‐like lesions and uteri in the abdominal cavity were harvested. Concentrations of several cytokines in sera and cyst fluids were measured using Bio‐Plex Suspension Array System. IL‐33 localization was determined by immunohistochemistry. Gene expression of inflammatory cytokines in the endometriosis‐like lesions or the eutopic endometrium was evaluated by real‐time RT‐PCR. Results After 14 days of TSS treatment, the numbers of endometriosis‐like cysts and cyst weight were significantly decreased. In TSS‐treated mice, the latency against heat stimuli was extended. Inflammatory cytokine concentrations in sera were not changed by TSS treatment. TSS intake decreased IL‐33 mRNA expression in endometriosis‐like lesions and led to the tendency of attenuation of the elevated IL‐33 synthesis in the cyst fluids of lesions. Conclusion These results suggest the TSS ameliorated the hyperalgesia and lesion formation on the LPS‐accelerated endometriosis‐like model. TSS represents a possible ideal target of novel therapeutics for endometriosis patients with dysmenorrhea.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- Altered maturation and function of peritoneal macrophages: Possible role in pathogenesis of endometriosis via openalex
- A novel anti-dysmenorrhea therapy with cyclic administration of two Japanese herbal medicines. via openalex
- Anti-endometrial IgM autoantibodies in endometriotic patients: a preliminary study. via openalex
- Central and Peripheral Pain Generators in Women with Chronic Pelvic Pain: Patient Centered Assessment and Treatment via openalex
- Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis via openalex
- Effect of Lignocaine on IL-6, IL-8, and MCP-1 in Peritoneal Macrophages and Endometriotic Stromal Cells via openalex
- Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial via openalex
- Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator via openalex
- Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex
- Inhibition of <scp>IAP</scp> (inhibitor of apoptosis) proteins represses inflammatory status <i>via</i> nuclear factor‐kappa B pathway in murine endometriosis lesions via openalex
- Interleukin-33 modulates inflammation in endometriosis via openalex
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? via openalex
- Lipopolysaccharide-promoted proliferation of endometriotic stromal cells via induction of tumor necrosis factor α and interleukin-8 expression via openalex
- Lipopolysaccharide promotes the development of murine endometriosis‐like lesions via the nuclear factor‐kappa B pathway via openalex
- Modulation of neutrophil apoptosis by plasma and peritoneal fluid from patients with advanced endometriosis via openalex
- New insights into the efficacy of <scp>SR</scp>‐16234, a selective estrogen receptor modulator, on the growth of murine endometriosis‐like lesions via openalex
- Parthenolide reduces cell proliferation and prostaglandin estradiol synthesis in human endometriotic stromal cells and inhibits development of endometriosis in the murine model via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Role of cytokines in endometriosis via openalex
- Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis via openalex
- Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population via openalex
- Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice via openalex
- Valproic Acid and Progestin Inhibit Lesion Growth and Reduce Hyperalgesia in Experimentally Induced Endometriosis in Rats via openalex
- W2010180179 via openalex
- W4406058850 via openalex
- W2035006335 via openalex
- W2042543920 via openalex
- W2068249081 via openalex
- W2082134078 via openalex
- W1969841288 via openalex
- W2124559476 via openalex
- W2167318005 via openalex
- W2219450326 via openalex
- W1891787316 via openalex
- W2285764647 via openalex
- W1503834335 via openalex
- W1245348047 via openalex
- W2521483984 via openalex
Cited by (7)
- Terapias complementares no tratamento de endometriose: uma revisão integrativa 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Large Haemoperitoneum Caused by a Ruptured Endometrioma: A Case Report 2022
- Rupture of ovarian endometriotic cyst complicated with endometriosis: A case report 2021
- Novel therapeutic strategy: antiinflammatory reagents 2021
- Efficacy of Tokishakuyakusan add‐on therapy with low‐dose oral contraceptive pills on endometriosis patients with dysmenorrhea 2020
- Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies 2020
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:35.348889+00:00
License: CC0
· commercial use OK